key: cord-0289240-vleeiqc0 authors: Budhraja, Anshul; Basu, Anubhav; Gheware, Atish; Abhilash, Dasari; Rajagopala, Seesandra; Pakala, Suman; Sumit, Madhuresh; Ray, Animesh; Arulselvi, S; Mathur, Purva; Nambirajan, Aruna; Kumar, Sachin; Gupta, Ritu; Wig, Naveet; Trikha, Anjan; Guleria, Randeep; Sarkar, Chitra; Gupta, Ishaan; Jain, Deepali title: Molecular signature of postmortem lung tissue from COVID-19 patients suggests distinct trajectories driving mortality date: 2022-04-12 journal: bioRxiv DOI: 10.1101/2021.11.08.467705 sha: 8a48096163f15121a98d17efb533cf562d034636 doc_id: 289240 cord_uid: vleeiqc0 The precise molecular mechanisms behind life-threatening lung abnormalities during severe SARS-CoV-2 infections are still unclear. To address this challenge, we performed whole transcriptome sequencing of lung autopsies from 31 patients suffering from severe COVID-19 related complications and 10 uninfected controls. Using a metatranscriptome analysis of lung tissue samples we identified the existence of two distinct molecular signatures of lethal COVID-19. The dominant “classical” signature (n=23) showed upregulation of unfolded protein response, steroid biosynthesis and complement activation supported by massive metabolic reprogramming leading to characteristic lung damage. The rarer signature (n=8) potentially representing “Cytokine Release Syndrome” (CRS) showed upregulation of cytokines such IL1 and CCL19 but absence of complement activation and muted inflammation. Further, dissecting expression of individual genes within enriched pathways for patient signature suggests heterogeneity in host response to the primary infection. We found that the majority of patients cleared the SARS-CoV-2 infection, but all suffered from acute dysbiosis with characteristic enrichment of opportunistic pathogens such as Staphylococcus cohnii in “classical” patients and Pasteurella multocida in CRS patients. Our results suggest two distinct models of lung pathology in severe COVID-19 patients that can be identified through the status of the complement activation, presence of specific cytokines and characteristic microbiome. This information can be used to design personalized therapy to treat COVID-19 related complications corresponding to patient signature such as using the identified drug molecules or mitigating specific secondary infections. ). Histopathological evaluation 155 Formalin-fixed, paraffin-embedded (FFPE) lung tissue blocks were processed and stained with 156 hematoxylin and eosin using a standardized procedure. Two thoracic pathologists (DJ and AN) 157 independently evaluated the slides. The following features: the extent of lung damage, injury, 158 inflammation, presence or absence of hyaline membrane formation, lymphocyte infiltration, 159 organizing pneumonia, alveolar fibrin deposition, fibrosis, and histologic features of type 2 160 pneumocyte hyperplasia, were noted and documented. Connectivity Map (CMap) (Lamb et al., 2006) analysis was performed using the online portal 217 https://clue.io/cmap to determine perturbagens (potential drugs reversing the aberrant gene 218 expression) using the L1 version of CMap with L1000 data repository, Touchstone data set as 219 a benchmark for assessing connectivity among perturbagens and Individual query option. The 220 pertubagens were further filtered for potential therapeutic drugs. Reads not mapped to the human genome were filtered to remove low complexity 223 (entropy>=0.7) , human rRNA and mitochondrial reads using BBMAP toolkit (version 224 38.90) (Bushnell, 2014) . The filtered unmapped reads were then input into Seal (from the suite 225 of bbtools) and binned into bacterial rRNA (using SILVA bacterial rRNA database)(Quast et al., Lung tissue biopsy samples were collected from post mortem COVID-19 affected and control patients. The tissue samples were first evaluated for clinical physiology. The host rRNA was depleted prior to 268 NGS library prep, the samples were then sequenced at an average depth of ~47 million reads per 269 sample. The sequence reads were filtered based on read quality. Filtered reads were used for aligned to the human reference genome GRCh38 (gencode v36) to summarize gene counts. The alignment rate ranged from 60.0% to 89.6% with a mean of 83.72 ± 6.72% ( Figure To identify biological processes implicated in the host response to SARS-CoV-2, we performed Figure S3E ). Specific chemokines such as CCL16 were also upregulated in only the G2 group. 423 We find further evidence of distinct inflammatory response within the G2 group through the Proliferating basal cells and TREM2+ dendritic cells were increased in G2 patients compared to G1. C) Bar plots of Connectivity Map (CMap) Scores for potential disease inducers (purple) and potential 487 therapeutic compounds. (green) for G1 and G2 groups of patients respectively. Cell-type deconvolution analysis maps altered lung cellular profile 489 Gene expression re-wiring can also be caused due to change in the proportion of different In-silico drug screening using Connectivity maps 515 We performed connectivity map (CMap) analysis with differentially expressed genes from G1 To identify the microbial signature in patient lung tissue we performed a metatranscriptomic 531 analysis ( Figure 1) . Briefly, reads that did not align to the human genome (2.23 ± 0.46% ; Figure 532 S1C, Supplementary File 1) were filtered for low complexity sequences ( Figure S1D , Alveolar lipids in pulmonary disease. A 685 review Why the immune system fails to mount an adaptive immune 687 response to a COVID-19 infection [Review of Why the immune system fails to mount an adaptive 688 immune response to a COVID-19 infection Coinfections with Bacteria, Fungi, and Respiratory Viruses in Patients with SARS-CoV-693 2: A Systematic Review and Meta-Analysis. Pathogens Babraham bioinformatics -FastQC A quality control tool for high throughput sequence data Unique inflammatory profile is associated with higher SARS-CoV-2 acute 700 respiratory distress syndrome (ARDS) mortality Stimulation of 703 hepatic acute phase response by cytokines and glucocorticoids ImmPort, 707 toward repurposing of open access immunological assay data for translational and clinical 708 research Trimmomatic: a flexible trimmer for Illumina sequence 710 data BBMap: A Fast, Accurate, Splice-Aware Aligner Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre 716 descriptive study. The Lancet Infectious Diseases The unfolded protein response in virus infections Application of respiratory metagenomics for COVID-19 patients on the intensive care unit 723 to inform appropriate initial antimicrobial treatment and rapid detection of nosocomial 724 transmission Coronavirus Disease 2019, Superinfections, and Antimicrobial 726 Development: What Can We Expect? Clinical Infectious Diseases: An Official Publication of the 727 Infectious Diseases Society of America Comprehensive transcriptomic analysis of 730 COVID-19 blood, lung, and airway A time-resolved proteomic and diagnostic map characterizes COVID-19 735 disease progression and predicts outcome Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A 738 multi-center case-control study from India STAR: ultrafast universal RNA-seq aligner CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and 746 expression levels are associated with disease severity An interactive web-based dashboard to track COVID-19 in 748 real time Mast cell-specific inactivation of Fosb exacerbates release of pro-inflammatory mediators 751 in models of systemic anaphylaxis and lipopolysaccharide-induced sepsis MultiQC: summarize analysis results for 754 multiple tools and samples in a single report The role of co-infections and secondary infections in patients 756 with COVID-19. Pneumonia Treatments in Covid-758 19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential 759 threat for drug-induced liver injury? Alpha-1-acid glycoprotein GENCODE 765 reference annotation for the human and mouse genomes The role for the metagenome in the pathogenesis of Surfactant and its role in the pathobiology of pulmonary 771 infection CoV-2 protein interaction map reveals targets for drug repurposing Government of India, & Ministry of Health and Family Welfare The emergence of post-COVID-19 mucormycosis in 781 India: Can we prevent it? Deciphering the TCR Repertoire to Solve the 783 COVID-19 Mystery GSVA: gene set variation analysis for microarray 785 and RNA-seq data On the Alert for 789 Cytokine Storm: Immunopathology in COVID-19. Arthritis & Rheumatology CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven 794 The cytokine storm and COVID-19 Identification of novel subgenomic RNAs and noncanonical transcription initiation 799 signals of severe acute respiratory syndrome coronavirus Lung transcriptome of a COVID-19 patient and 801 systems biology predictions suggest impaired surfactant production which may be druggable by 802 29 surfactant therapy T-Cell Hyperactivation and 804 Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis Peroxisomes exhibit 807 compromised structure and matrix protein content in SARS-CoV-2-infected cells Association between angiotensinogen (AGT), angiotensin-converting 811 enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in 812 the southeast of Iran: a preliminary case-control study Enrichr: a comprehensive gene set enrichment analysis web server 817 2016 update The Connectivity 821 Map: using gene-expression signatures to connect small molecules, genes Bacterial co-infection and secondary infection in patients with COVID-825 19: a living rapid review and meta-analysis. Clinical Microbiology and Infection: The Official 826 Publication of the European Society of Clinical Microbiology and Infectious Diseases Fast gapped-read alignment with Bowtie 2 Coagulation dysfunction in COVID-19: The interplay between 832 30 inflammation, viral infection and the coagulation system Genomic mutations and changes in 894 protein secondary structure and solvent accessibility of SARS-CoV-2 (COVID-19 virus) Two distinct immunopathological 899 profiles in autopsy lungs of COVID-19 Automated machine learning optimizes and accelerates predictive modeling from 902 COVID-19 high throughput datasets Proteomic blood profiling in mild, severe and critical COVID-19 patients 6357. 906 pheatmap: Pretty Heatmaps Epidemiology of Mucormycosis in India. Microorganisms & The Indian Genome Variation 911 Genetic risk prediction of COVID-19 susceptibility and severity in the Indian 912 population Plasma Apolipoproteins A1/B and OxLDL Levels in Patients with 915 Covid-19 As Possible Markers of the Disease The SILVA ribosomal RNA gene database project: improved data processing and web-918 based tools Bacterial and Fungal Coinfection in Individuals With 921 Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing Diseases: An Official Publication of the Infectious Diseases Society of America & COVID-BioB study group Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors The Official Publication of the European Society of Clinical 929 Microbiology and Infectious Diseases Viral genomic, metagenomic and human transcriptomic characterization and 934 prediction of the clinical forms of COVID-19 Interferon-inducible antiviral effectors Enhanced expression of immune checkpoint receptors 939 during SARS-CoV-2 viral infection Differential Redistribution 945 of Activated Monocyte and Dendritic Cell Subsets to the Lung Associates with Severity of COVID-946 19. medRxiv : The Preprint Server for Health Sciences Coronavirus transcription: a perspective Evaluation of GRCh38 and de novo haploid genome assemblies demonstrates the enduring 954 quality of the reference assembly Interferon-stimulated genes and their antiviral effector 956 functions … members of the Collaborative OPAI-IJO 960 Epidemiology, clinical 961 profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis 962 in 2826 patients in India -Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 963 (COSMIC) Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens Proteomics Identify Biomarkers and Pathogenesis of COVID-19 Fungal and bacterial coinfections increase mortality of severely ill COVID-974 19 patients Proteolytic activation of the 976 SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research Sustained expression of 980 inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent 981 plasma donors Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing 984 NADPH Oxidases 1 and 4 and Cytochrome P450 2E1 A hypothesis for pathobiology and treatment of COVID-19: The 987 centrality of ACE1/ACE2 imbalance Patients Carry Tenascin-C and Fibrinogen-β in Triggering Inflammatory Signals in Cells of Distant 990 Cytokine Storm in COVID-19: The 992 Current Evidence and Treatment Strategies The trinity of COVID-19: 994 immunity, inflammation and intervention Effsize -a package for efficient effect size computation A molecular cell atlas of the human lung from single-1001 cell RNA sequencing Standardized nomenclature and 1003 open science in Human Genomics Identification of potential mRNA panels for severe acute 1005 respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray 1006 dataset and bioinformatics methods Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience. Infection and Drug Resistance A serum proteome signature to 1015 predict mortality in severe COVID-19 patients Comprehensive analysis of TCR repertoire in COVID-19 using 1019 single cell sequencing A 1022 single-cell transcriptomic landscape of the lungs of patients with COVID-19 Bulk tissue cell type deconvolution with 1025 multi-subject single-cell expression reference Ggplot2 Improved metagenomic analysis with Kraken 2 A new coronavirus associated with human respiratory disease in 1032 Transcriptional and proteomic insights into the host response in fatal COVID-19 cases Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear 1041 cells in COVID-19 patients clusterProfiler: an R package for comparing 1043 biological themes among gene clusters Metatranscriptomic Characterization Clinical Infectious 1047 Diseases: An Official Publication of the Infectious Diseases Society of America Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to 1055 COVID-19